The maker of Claude wants AI labs, including itself, to prepare for a coordinated slowdown if models begin building their own ...
Multiple milestones achieved or on track across wholly owned and partnered programs REC-1245 (RBM39 degrader): Early clinical data in solid tumors demonstrate a well-tolerated safety profile and ...